These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10456904)

  • 1. Assessment of immunity to mycobacterial infection with luciferase reporter constructs.
    Snewin VA; Gares MP; Gaora PO; Hasan Z; Brown IN; Young DB
    Infect Immun; 1999 Sep; 67(9):4586-93. PubMed ID: 10456904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
    Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
    Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria.
    Neyrolles O; Gould K; Gares MP; Brett S; Janssen R; O'Gaora P; Herrmann JL; Prévost MC; Perret E; Thole JE; Young D
    J Immunol; 2001 Jan; 166(1):447-57. PubMed ID: 11123323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of in vitro immunity to Mycobacterium tuberculosis in a human peripheral blood infection model using a luciferase reporter construct of M. tuberculosis H37Rv.
    Al-Attiyah R; El-Shazly A; Mustafa AS
    Clin Exp Immunol; 2006 Sep; 145(3):520-7. PubMed ID: 16907922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of mice with recombinant bacille Calmette-Guérin harboring Rv1357c protects similarly to native BCG.
    Flores-Valdez MA; Aceves-Sánchez MJ; Montero-Pérez SA; Sánchez-López AD; Gutiérrez-Pabello JA; Hernández-Pando R
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):774-6. PubMed ID: 22507759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against
    Bickett TE; McLean J; Creissen E; Izzo L; Hagan C; Izzo AJ; Silva Angulo F; Izzo AA
    Front Immunol; 2020; 11():1202. PubMed ID: 32625209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosodium Urate Crystals Promote Innate Anti-Mycobacterial Immunity and Improve BCG Efficacy as a Vaccine against Tuberculosis.
    Taus F; Santucci MB; Greco E; Morandi M; Palucci I; Mariotti S; Poerio N; Nisini R; Delogu G; Fraziano M
    PLoS One; 2015; 10(5):e0127279. PubMed ID: 26023779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Mycobacteria for the Production of Self-Assembling Biopolyesters Displaying Mycobacterial Antigens for Use as a Tuberculosis Vaccine.
    Lee JW; Parlane NA; Rehm BHA; Buddle BM; Heiser A
    Appl Environ Microbiol; 2017 Mar; 83(5):. PubMed ID: 28087528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.
    Sweeney KA; Dao DN; Goldberg MF; Hsu T; Venkataswamy MM; Henao-Tamayo M; Ordway D; Sellers RS; Jain P; Chen B; Chen M; Kim J; Lukose R; Chan J; Orme IM; Porcelli SA; Jacobs WR
    Nat Med; 2011 Sep; 17(10):1261-8. PubMed ID: 21892180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro.
    Post FA; Manca C; Neyrolles O; Ryffel B; Young DB; Kaplan G
    Infect Immun; 2001 Mar; 69(3):1433-9. PubMed ID: 11179309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
    Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
    Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous Boosting With
    Liu SJ; Tian SC; Zhang YW; Tang T; Zeng JM; Fan XY; Wang C
    Front Immunol; 2020; 11():2036. PubMed ID: 32983151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putative roles of a proline-glutamic acid-rich protein (PE3) in intracellular survival and as a candidate for subunit vaccine against Mycobacterium tuberculosis.
    Singh SK; Kumari R; Singh DK; Tiwari S; Singh PK; Sharma S; Srivastava KK
    Med Microbiol Immunol; 2013 Oct; 202(5):365-77. PubMed ID: 23708146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Rv2031c-Rv2626c fusion protein in Mycobacterium smegmatis enhances bacillary survival and modulates innate immunity in macrophages.
    Jiang H; Luo TL; Kang J; Xu ZK; Wang LM
    Mol Med Rep; 2018 May; 17(5):7307-7312. PubMed ID: 29568875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a lipid-based preparation from Mycobacterium smegmatis in a murine model of progressive pulmonary tuberculosis.
    García Mde L; Borrero R; Lanio ME; Tirado Y; Alvarez N; Puig A; Aguilar A; Canet L; Mata Espinoza D; Barrios Payán J; Sarmiento ME; Hernández-Pando R; Norazmi MN; Acosta A
    Biomed Res Int; 2014; 2014():273129. PubMed ID: 25548767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.
    Mohanty S; Jagannathan L; Ganguli G; Padhi A; Roy D; Alaridah N; Saha P; Nongthomba U; Godaly G; Gopal RK; Banerjee S; Sonawane A
    J Biol Chem; 2015 May; 290(21):13321-43. PubMed ID: 25825498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection.
    Prendergast KA; Counoupas C; Leotta L; Eto C; Bitter W; Winter N; Triccas JA
    Vaccine; 2016 May; 34(23):2608-15. PubMed ID: 27060378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luciferase in vivo expression technology: use of recombinant mycobacterial reporter strains to evaluate antimycobacterial activity in mice.
    Hickey MJ; Arain TM; Shawar RM; Humble DJ; Langhorne MH; Morgenroth JN; Stover CK
    Antimicrob Agents Chemother; 1996 Feb; 40(2):400-7. PubMed ID: 8834887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.